Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
08/2010
08/17/2010US7776620 Hapten-carrier conjugates for treating and preventing nicotine addiction
08/17/2010US7776546 Using immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics
08/17/2010US7776526 conatacting an extracellular haemoglobin sample from annelids with dissociating agent e.g. a mixture containing dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP) hydrochloride or beta-mercaptoethanol and a dissociation buffer for a sufficient length of time in order to separate the chains
08/17/2010US7776518 Detection of survivin in the biological fluids of cancer patients
08/17/2010US7776340 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43
08/17/2010CA2395431C Separation of fibrinogen from plasma proteases
08/17/2010CA2222679C Separating unmodified hemoglobin from cross-linked hemoglobin
08/17/2010CA2182905C Method for ordering macromolecules by means of a moving meniscus, and uses thereof
08/12/2010WO2010091122A1 Extended recombinant polypeptides and compositions comprising same
08/12/2010WO2010089695A1 Process for producing acidulated 50% concentrated solution and dry powder of peptides from protein products and waste of animal, fish and aquaculture origin
08/12/2010WO2010089126A2 Immunoglobulin glycosylation pattern analysis
08/12/2010US20100204459 Systems and methods for producing multi-component colloidal structures
08/12/2010US20100204458 Process for the Production of Immunogenic Compositions
08/12/2010US20100204453 Antibodies to tumor associated proteins
08/12/2010US20100204452 Purification of Factor VIII Using a Mixed-Mode or Multimodal Resin
08/12/2010US20100204449 Methods and intermediates for chemical synthesis of polypeptides and proteins
08/12/2010US20100204445 Dockerin polypeptide and method of purifying recombinant fused protein using the same
08/12/2010US20100203651 Methods and compounds for phototransfer
08/12/2010US20100203589 Method for obtaining active beta-ngf
08/12/2010CA2750977A1 Immunoglobulin glycosylation pattern analysis
08/12/2010CA2748314A1 Extended recombinant polypeptides and compositions comprising same
08/11/2010EP2216083A2 Conjugates of magnetic polymer particles and carboxymethylated aspartic acid
08/11/2010EP2215234A1 Method for production and purification of macromolecular complexes
08/11/2010EP2215117A1 Antibody purification by cation exchange chromatography
08/11/2010EP2215105A1 Keratin derivatives and methods of making the same
08/11/2010EP2214809A1 Apparatus for purifying molecules
08/11/2010EP2214699A2 Method, composition, and article of manufacture for providing alpha-1 antitrypsin
08/11/2010EP1572329B1 Device and method for preparatory electrophoresis
08/11/2010EP0988063B2 Process for reducing the concentration of viral and molecular pathogens in a biological material
08/11/2010CN101801999A Production of 2S canola protein involving ion exchange
08/11/2010CN101799448A Method for separating proteins by capillary electrophoresis and buffer compositions for capillary electrophoresis
08/11/2010CN101798587A Method for separating and purifying corn anti-hypertensive peptides
08/11/2010CN101798350A Fusion protein of human interferon alpha-2b and human thymosin alpha1, and preparation thereof
08/11/2010CN101798345A Method for decorating collagen protein
08/11/2010CN101798344A Method for enriching albumin from human urine on large scale
08/11/2010CN101798336A Anti-tumour compound with tracking function
08/11/2010CN101798335A Purification method of thymosin extrasin alpha 1
08/11/2010CN101798334A Purification method of human parathyroid hormone (1-34)
08/11/2010CN101797384A Tri-union compound immunopotentiator and method for preparing same
08/11/2010CN101240011B Fast large preparation method for high-purity isophycocyanin
08/11/2010CN101157721B Method for preparing streptomyces whole protein
08/10/2010US7772368 Deletion forms of IGE-dependent histamine releasing factor having histamine releasing activity, HRF-binding peptides and the uses thereof
08/10/2010US7772179 which binds to cell through ligand and activated by emitted light; photosensitizer is hematoporphyrin; transport ligand is peptide; conjugate of transferrin-hematoporphyrin which destroys cancerous cells in presence of luminol; tissue targeted
08/10/2010US7771970 Protein fusion comprising sequences capable of being cleaved by ubiquitin cleavage enzyme; isolating heterologous expressed, recombinant polypeptide from mixture
08/10/2010US7771966 Polypeptide cleavage process
08/10/2010US7771938 Nonlinear spectroscopic methods for identifying and characterizing molecular interactions
08/10/2010CA2398834C Protein/solubility folding assessed by structural complementation
08/10/2010CA2319309C Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
08/10/2010CA2124583C Synthetic compounds and compositions with enhanced cell binding
08/05/2010WO2010040147A9 Site-specific n-terminal modifications of proteins and conjugate formation
08/05/2010US20100197894 Method and apparatus for material separation using acoustic energy
08/05/2010US20100197892 Organosilicon-functional phase transfer catalysts
08/05/2010US20100197891 Method for peptide synthesis
08/05/2010US20100197573 Transglutaminase Mediated Conjugation of Growth Hormone
08/05/2010US20100197569 Cross-linked glycopeptide-cephalosporin antibiotics
08/05/2010US20100197566 Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute
08/05/2010US20100197030 Xanthene dyes comprising a sulfonamide group
08/05/2010US20100197009 Antibody or Fragment Thereof Recognizing AvitagTM and Uses Thereof
08/05/2010US20100196988 Bioreactive Agents
08/05/2010US20100196952 Method for preparative in vitro protein biosynthesis
08/05/2010US20100196951 Antitoxin Destabilization Technology
08/05/2010US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS
08/04/2010EP2213653A2 Method for the stereoselective preparation of amino acid derivatives
08/04/2010EP1864129B1 Doxorubicin immunoassay
08/04/2010CN201538749U Instant reactor for bio-pharmaceuticals
08/04/2010CN101796065A Method for purifying the factor VIII and the Von Willebrand factor
08/04/2010CN101796064A Method for producing peptide
08/04/2010CN101796063A Methods of treatment using glycopegylated G-CSF
08/04/2010CN101792738A Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof
08/04/2010CN101792490A Method for recycling albumin in Cohn's fraction IV precipitate
08/04/2010CN101792487A Method for synthesizing Laterocidin compound by solid phase cyclization
08/04/2010CN101792486A Method for combining caspofungin acetate
08/04/2010CN101792485A Alpha-type conus polypeptide and application thereof
08/04/2010CN101792482A Method for purifying gonadotropins
08/04/2010CN101792481A Purification method of human chorionic gonadotropin (HCG)
08/04/2010CN101792480A Method for packing histidine-tagged protein with nano silica
08/04/2010CN101791520A Polyether sulfone/hydroxyapatite composite membrane and preparation method and application thereof
08/04/2010CN101791490A Packing material for liquid chromatography and process for separation and purification of biopolymer by means of the packing material
08/04/2010CN101092447B Fibrin enzymolysis auxiliary agent from stalk stuff of plant
08/03/2010US7767795 High pressure refolding of protein aggregates and inclusion bodies
08/03/2010US7767794 5-fluoro-uracil immunoassay
08/03/2010US7767787 Substance for obtaining highly effective tumor medications as well as a process
08/03/2010US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename
08/03/2010US7767418 Expression vector comprising nucleotide sequences coding immunoglobulin fusion comprising transient receptor potential cation channel for use in identifying modulator for treatment and prevention of nervous system disorders
08/03/2010CA2468295C Glycoprotein remodeling using endoglycanases
07/2010
07/29/2010WO2010085495A1 Compositions and methods of treating inflammatory and autoimmune diseases
07/29/2010WO2010083859A1 Device and method for material separation
07/29/2010WO2010042654A3 Recombinant nell protein production
07/29/2010US20100190965 Method for separation of immunoglobulin monomers
07/29/2010US20100190963 Stirred Tank Reactor And Method
07/29/2010US20100190958 Pure vancomycin hydrochloride
07/29/2010US20100190775 Pyrimidodiazepinone derivative
07/29/2010US20100190660 Methods, Compositions And Libraries Pertaining To PNA Dimer And PNA Oligomer Synthesis
07/29/2010US20100190263 Bubble Techniques for a Droplet Actuator
07/29/2010US20100190234 methods for the formation of disulphide bonds
07/29/2010US20100190210 Protein Purification
07/29/2010US20100189658 Imaging probes
07/29/2010US20100189651 Modified antibody compositions, methods of making and using thereof
07/29/2010US20100188559 System and method for high numeric aperture imaging systems
07/29/2010US20100187114 High-performing electrophoresis gels with extended shelf lives